Frequencies of HLA-A2 alleles in five U.S. population groups

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

Steven A. Rosenberg, James Chih‐Hsin Yang, Douglas J. Schwartzentruber et al. · Nature Medicine · 1998 · 1.8K citations

Medicine, Immunology, Oncology +16

Locus‐specific amplification of HLA class I genes from genomic DNA: locus‐specific sequences in the first and third introns of HLA‐A, ‐B, and ‐C alleles

Nezih Cereb, Peter Maye, S. Lee et al. · Tissue Antigens · 1995 · 301 citations

Life Sciences, Genetics, Molecular Genetics +13

Identification of HLA-A2–Restricted T-Cell Epitopes Derived From the MUC1 Tumor Antigen for Broadly Applicable Vaccine Therapies

Peter Brossart, Kathrin Heinrich, Gernot Stuhler et al. · Blood · 1999 · 298 citations

Life Sciences, Immunology, Oncology +17

Nomenclature for factors of the HLA system, 1998

J. G. Bodmer, S. G. E. Marsh, E. D. Albert et al. · Tissue Antigens · 1999 · 263 citations

Life Sciences, Immunology, Molecular Genetics +12

Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens.

Thomas Wölfel, E. Klehmann, Claude P. Muller et al. · The Journal of Experimental Medicine · 1989 · 220 citations · Full text

Life Sciences, Immunology, Oncology +17